Dashboard
Manage Tickers

BCABBioAtla, Inc.

Nasdaq bioatla.com


$ 2.43 $ -0.10 (-3.95 %)    

Thursday, 18-Apr-2024 15:59:55 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 422.80 $ -2.43 (-0.57 %)
DIA $ 377.76 $ 0.39 (0.1 %)
SPY $ 499.54 $ -1.03 (-0.21 %)
TLT $ 88.82 $ -0.45 (-0.5 %)
GLD $ 220.32 $ 0.75 (0.34 %)
$ 2.43
$ 2.48
$ 0.00 x 0
$ 0.00 x 0
$ 2.40 - $ 2.53
$ 1.24 - $ 4.07
361,731
na
116.1M
$ 2.45
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-26-2024 12-31-2023 10-K
2 11-07-2023 09-30-2023 10-Q
3 08-01-2023 06-30-2023 10-Q
4 05-11-2023 03-31-2023 10-Q
5 03-23-2023 12-31-2022 10-K
6 11-04-2022 09-30-2022 10-Q
7 08-09-2022 06-30-2022 10-Q
8 05-05-2022 03-31-2022 10-Q
9 02-28-2022 12-31-2021 10-K
10 11-15-2021 09-30-2021 10-Q
11 08-13-2021 06-30-2021 10-Q
12 05-12-2021 03-31-2021 10-Q
13 03-24-2021 12-31-2020 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

jmp-securities-reiterates-market-outperform-on-bioatla-maintains-12-price-target
JMP Securities Reiterates Market Outperfor...
03/28/2024 14:34:55

JMP Securities analyst Reni Benjamin reiterates BioAtla (NASDAQ:BCAB) with a Market Outperform and maintains $12 price target.

hc-wainwright--co-maintains-buy-on-bioatla-lowers-price-target-to-7
HC Wainwright & Co. Maintains Buy on BioAt...
03/27/2024 10:26:29

HC Wainwright & Co. analyst Arthur He maintains BioAtla (NASDAQ:BCAB) with a Buy and lowers the price target from $10 to...

bioatla-q4-eps-056-beats-079-estimate
BioAtla Q4 EPS $(0.56) Beats $(0.79) Estimate
03/26/2024 21:35:40

BioAtla (NASDAQ:BCAB) reported quarterly losses of $(0.56) per share which beat the analyst consensus estimate of $(0.79) by 29...

bioatla-q4-earnings-insights
BioAtla: Q4 Earnings Insights
03/26/2024 21:35:13

earnings-scheduled-for-march-26-2024
Earnings Scheduled For March 26, 2024
03/26/2024 08:47:27

Companies Reporting Before The Bell • bluebird bio (NASDAQ:BLUE) is likely to report quarterly loss at $0.66 per share on reve...

preview-bioatlas-earnings
Preview: BioAtla's Earnings
03/25/2024 16:00:39

around-2m-bet-on-this-healthcare-stock-check-out-these-4-penny-stocks-insiders-are-aggressively-buying
Around $2M Bet On This Healthcare Stock? C...
12/20/2023 13:31:54

The Dow Jones index closed higher by around 250 points on Tuesday. When insiders purchase or sell shares, it indicates their co...

12-health-care-stocks-moving-in-mondays-after-market-session
12 Health Care Stocks Moving In Monday's A...
12/18/2023 21:31:50

bioatla-hosting-virtual-rd-day-to-highlight-ba3071-cab-ctla-4-phase-1-data-in-multiple-solid-tumor-types
BioAtla Hosting Virtual R&D Day To Highlig...
12/13/2023 13:23:30

Multiple confirmed responses and durable disease control observed Emerging differentiated safety profile enables further explor...

jmp-securities-reiterates-market-outperform-on-bioatla-maintains-12-price-target
JMP Securities Reiterates Market Outperfor...
12/05/2023 14:17:31

JMP Securities analyst Reni Benjamin reiterates BioAtla (NASDAQ:BCAB) with a Market Outperform and maintains $12 price target.

bioatla-presented-phase-2-clinical-trial-data-at-the-iaslc-2023-north-america-conference-on-lung-cancer-and-virtual-kol-event
BioAtla Presented Phase 2 Clinical Trial D...
12/05/2023 13:07:36

Results from the Phase 2 BA3011 clinical non-small cell lung cancer (NSCLC) study demonstrated promising clinical benefits in h...

12-health-care-stocks-moving-in-mondays-intraday-session
12 Health Care Stocks Moving In Monday's I...
12/04/2023 17:31:02

hc-wainwright--co-maintains-buy-on-bioatla-lowers-price-target-to-10
HC Wainwright & Co. Maintains Buy on BioAt...
11/08/2023 13:11:40

HC Wainwright & Co. analyst Arthur He maintains BioAtla (NASDAQ:BCAB) with a Buy and lowers the price target from $17 to...

bioatla-q3-2023-cash-cash-equivalents-1413m
BioAtla Q3 2023 Cash, Cash Equivalents $14...
11/07/2023 21:04:41

bioatla-sees-h2-2025-cash-balance-1413m
BioAtla Sees H2 2025 Cash Balance $141.3M
11/07/2023 21:04:09

earnings-scheduled-for-november-7-2023
Earnings Scheduled For November 7, 2023
11/07/2023 11:34:30

Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings for its third quarter.

bioatla-provides-guidance-on-near-term-milestones-and-plans-to-announce-third-quarter-2023-financial-results-and-business-update-on-november-7-2023
BioAtla Provides Guidance on Near-Term Mil...
10/10/2023 11:35:34

Submitted abstract on CAB-AXL-ADC, BA3011, in non-small cell lung cancer (NSCLC) to the IASLC 2023 North America Conference o...

stocks-that-hit-52-week-lows-on-monday
Stocks That Hit 52-Week Lows On Monday
10/02/2023 17:00:10

  On Monday, 369 companies set new 52-week lows.

analyst-ratings-for-bioatla
Analyst Ratings for BioAtla
09/25/2023 16:00:36

jp-morgan-maintains-overweight-on-bioatla-lowers-price-target-to-14
JP Morgan Maintains Overweight on BioAtla,...
09/25/2023 13:36:02

JP Morgan analyst Brian Cheng maintains BioAtla (NASDAQ:BCAB) with a Overweight and lowers the price target from $17 to $14.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

04/22/2024 Dick's Sporting Goods, Inc. (DKS)
04/22/2024 Innodata Inc. (INOD)
04/22/2024 Fox Factory Holding Corp. (FOXF)
04/23/2024 Lantronix, Inc. (LTRX)

NEW CASE INVESTIGATION

AnaptysBio Inc (ANAB)